Orly Baror Gal
About Orly Baror Gal
Orly Baror Gal serves as the Director of Clinical Affairs at Sensible Medical Innovations Ltd. and has over a decade of experience in the medical device sector, including previous roles at Gil Medical Group Ltd. and Allium Ltd.
Current Role at Sensible Medical Innovations
Orly Baror Gal serves as the Director of Clinical Affairs at Sensible Medical Innovations Ltd. since 2022. In this role, she oversees clinical operations and ensures the effective implementation of medical devices. Her responsibilities include managing clinical trials and collaborating with healthcare professionals to enhance product development.
Previous Experience in Clinical Affairs
Before joining Sensible, Orly held the position of Director of Clinical Affairs at Allium Ltd. from 2019 to 2022. She was responsible for clinical strategy and execution, contributing to the advancement of medical technologies. Prior to that, she worked as a Surgical Products Line Manager at Gil Medical Group Ltd. from 2017 to 2019.
Educational Background and Certifications
Orly Baror Gal earned her MBA with a specialization in Finance from Bar-Ilan University, completing her studies from 2014 to 2016. She also holds a B.Sc in Biomedical Engineering from Ben-Gurion University of the Negev, which she completed from 2004 to 2008. Additionally, she has obtained CRA and GCP certificates from Bioforum, enhancing her qualifications in clinical research.
Experience in Medical Device Sector
Orly has a strong background in sales and business development within the medical device sector. Her experience includes managing collaborations with Key Opinion Leaders (KOLs) and providing clinical application support. She has worked in various capacities, including as a Clinical Application Specialist/Product Manager at Alma Lasers from 2011 to 2016 and as a Clinical Manager at TechsoMed from 2016 to 2017.
Early Career and Research Experience
Orly began her career as a Chemical Research Assistant at Ben-Gurion University of the Negev from 2007 to 2008. This role provided her with foundational research experience in a scientific environment, contributing to her expertise in the medical field.